Skip Navigation
NIH

Talking Glossary of Genetic Terms

Listen to Definition

William Pavan, Ph.D. defines Restriction Fragment Length Polymorphism (RFLP)

Restriction Fragment Length Polymorphism (RFLP)

Restriction fragment length polymorphism (RFLP) is a type of polymorphism that results from variation in the DNA sequence recognized by restriction enzymes. These are bacterial enzymes used by scientists to cut DNA molecules at known locations. RFLPs (pronounced "rif lips") are used as markers on genetic maps. Typically, gel electrophoresis is used to visualize RFLPs.

How to cite this term How to cite this term for research papers


A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Restriction Fragment Length Polymorphism (RFLP)

Restriction fragment length polymorphism (RFLP) is a type of polymorphism that results from variation in the DNA sequence recognized by restriction enzymes. These are bacterial enzymes used by scientists to cut DNA molecules at known locations. RFLPs (pronounced "rif lips") are used as markers on genetic maps. Typically, gel electrophoresis is used to visualize RFLPs.

Narration Transcription

RFLPs have been very useful to use as markers for following a genomic DNA, either from human or other animals. What is it, though? So basically, if you follow the sequence of DNA, particular sites, a series of four to eight nucleic acids, results in a restriction site where an enzyme from bacteria can actually bind and cleave that DNA. So why is that useful? Well, we can take advantage of this fact to actually look for differences between people if they have that restriction enzyme site or not. So a single base difference between two people could result in either the presence or absence of that restriction site. So then, if you isolate that piece of DNA surrounding that site from two people, from one of them it will be cut by the enzyme and the other one it won't. And that results in a polymorphism, or difference between those two people. We typically see these, or we monitor these, by isolating the DNA, cutting it with that bacterial restriction enzyme, and running it on a gel using electrophoresis. In one person, without the enzyme site you'll see one band, and the person that has the enzyme site, you'll see two bands, representing the two cleaved products. So these differences in nucleic acid sequences and restriction enzyme binding sites just mean that there's a difference in the sequence between those two people. That sequence difference doesn't necessarily mean that there's a disease associated with it. It's a polymorphism that we could use to follow the inheritance of DNA.


Doctor Profile

William Pavan, Ph.D.

William Pavan, Ph.D.

Occupation
Senior Investigator, Genetic Disease Research Branch; Head, Mouse Embryology Section

Biography
Dr. Pavan's laboratory uses genomic tools to study how an embryo develops into a functioning organism. His group focuses on neural crest cells, a group of stem cells that differentiate into a variety of tissues throughout the body. In vertebrate development, neural crest cells form at the top of the neural tube. They then migrate throughout the body to populate the peripheral nervous system and form other tissues. When the genetic machinery that controls neural crest cell development goes awry, it can cause many human diseases, ranging from Waardenburg syndrome to cleft lip and palate.

How to cite this termHow to cite this term for research papers

About the Talking Glossary
all Top